# COMBINED PSMA-PET/CT AND MRI STAGING IN INTERMEDIATE AND HIGH-RISK PATIENTS PROSTATA-CANCER (COMBINE-P)

> **NCT07455097** · — · ACTIVE_NOT_RECRUITING · sponsor: **Heinrich-Heine University, Duesseldorf** · enrollment: 600 (estimated)

## Conditions studied

- Intermediate-risk Prostate Cancer
- High-risk Prostate Cancer

## Interventions

- **DIAGNOSTIC_TEST:** PSMA-11

## Key facts

- **NCT ID:** NCT07455097
- **Lead sponsor:** Heinrich-Heine University, Duesseldorf
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2026-01-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2026-03-06

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07455097

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07455097, "COMBINED PSMA-PET/CT AND MRI STAGING IN INTERMEDIATE AND HIGH-RISK PATIENTS PROSTATA-CANCER (COMBINE-P)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07455097. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*